Rush University Medical Center

Borgia headshotPrincipal Investigator:  Dr. Jeffrey Borgia

Disease: Lung cancer

Research Description: Early detection of lung cancer can save lives. Low‐dose computer tomography (CT) screening in high‐risk lung cancer patients has been shown to reduce mortality. However, only a small percentage of the suspicious lesions identified on CT scans are malignant, leading to unnecessary biopsies or surgeries in many patients. Dr. Borgia and his team are repurposing a blood diagnostic test Dr. Borgia developed with prior Cures Within Reach funding to help clinicians rule out non‐malignant lung cancer cases in other clinical circumstances. This research project will repurpose this diagnostic test to determine if it could help sort out malignant from non‐malignant lesions, thereby improving physician decision making, patient care and outcomes and reducing healthcare costs following a CT screening scan.

CWR funding role: Primary funder

CWR funding start date: July 2015 

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*

*required

If the link above doesn't work, please email susan@cureswithinreach.org with your Full Name and Email Address to sign up!

 

Cures Within Reach

info@cureswithinreach.org

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.

 

Monday the 21st. Copyright 2018 Cures Within Reach.